Option Care Health (NASDAQ:OPCH) Upgraded by Wall Street Zen to “Buy” Rating

Wall Street Zen upgraded shares of Option Care Health (NASDAQ:OPCH) from a hold rating to a buy rating in a research report report published on Saturday.

Other research analysts have also recently issued reports about the company. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Friday, October 31st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a report on Monday, December 29th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, December 9th. Barrington Research restated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research note on Friday, October 31st. Finally, TD Cowen dropped their target price on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating for the company in a report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $36.27.

Option Care Health Trading Down 0.6%

Shares of Option Care Health stock opened at $31.78 on Friday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05. The stock has a market capitalization of $5.04 billion, a PE ratio of 25.22, a P/E/G ratio of 1.98 and a beta of 0.80. Option Care Health has a 1-year low of $23.68 and a 1-year high of $35.53. The company’s fifty day simple moving average is $30.72 and its 200-day simple moving average is $29.42.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the firm’s stock in a transaction on Monday, November 3rd. The shares were acquired at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the purchase, the director directly owned 413,390 shares in the company, valued at $10,739,872.20. This trade represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.64% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds have recently made changes to their positions in the company. Durable Capital Partners LP boosted its stake in Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after buying an additional 4,720,988 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of Option Care Health by 17.3% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 4,001,307 shares of the company’s stock valued at $111,076,000 after acquiring an additional 590,913 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Option Care Health by 6.6% in the third quarter. Dimensional Fund Advisors LP now owns 3,796,396 shares of the company’s stock valued at $105,384,000 after purchasing an additional 235,413 shares in the last quarter. Norges Bank bought a new stake in Option Care Health in the second quarter worth $69,932,000. Finally, Jennison Associates LLC raised its stake in Option Care Health by 145.6% during the second quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock valued at $69,450,000 after purchasing an additional 1,267,660 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.